Since most anti-angiogenic strategies focus on inhibiting VEGF and its receptors22, controlling the miR-200–ZEB2–VEGF signaling axis by TBX1 may be an essential pathway for influencing tumor progression. This evidence concerns the gene ZEB2 and neoplasm.